ESTABLISHMENT LABS HOLDINGS (ESTA)

Establishment Labs to Announce First Quarter 2024 Financial Results on May 8

Establishment Labs Announces Participation in The Aesthetic Meeting 2024

Establishment Labs GAAP EPS of -$0.79 beats by $0.12, revenue of $31.56M in-line (NASDAQ:ESTA)

Establishment Labs reported fourth quarter and full-year 2023 financial results, beating GAAP EPS estimates by $0.12, with revenue in line.

Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

Establishment Labs Announces Participation in Two Upcoming Investment Conferences

Top Buys by Directors: Lewin's $164.1K Bet on ESTA

Establishment Labs announces amended credit facility with Oaktree (NASDAQ:ESTA)

Establishment Labs amends its $225 million term loan facility with Oaktree Capital Management, with changes to two tranches and interest rates.

Establishment Labs Announces Amended Credit Facility with Oaktree

Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28

Establishment Labs Announces Commercial Launch of Motiva Implants in China

Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023

Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander

Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Establishment Labs Announces Participation in Two Upcoming Investment Conferences

TD Cowen sees $200M opportunity for Establishment Labs' Motiva in China (ESTA)

TD Cowen said that the apparent approval of Establishment Labs (ESTA) Motiva breast implants in China unlocks a market opportunity worth up to $200M. Read more here.

Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning!

Establishment Labs reportedly wins Chinese approval for Motiva implants (NASDAQ:ESTA)

Establishment Labs (ESTA) has reportedly received Chinese regulatory approval for its Motiva breast implants, the day after the company cuts its 2023 forecast i

Relative Strength Alert For Establishment Labs Holdings

Why Establishment Labs Stock Is Crashing Today

The medtech company didn't have much good news for investors in its Q3 update.

(NASDAQ:ESTA)

Establishment Labs (ESTA) reports disappointing Q3 results, with GAAP EPS of -$1.12 missing estimates by $0.32 and revenue of $38.5M missing estimates by...

Establishment Labs Reports Third Quarter 2023 Financial Results

Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7

Establishment Labs' Motiva Flora for breast reconstruction gets FDA nod

The FDA grants 510(k) clearance to Establishment Labs' (ESTA) Motiva Flora SmoothSilk Tissue Expander. Read more here